Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

HIV Infection

Free Subscription 12.01.2026 8 AIDS 1 Am J Epidemiol 9 Clin Infect Dis 4 HIV Med 2 J Acquir Immune Defic Syndr 4 J Infect Dis 1 J Med Virol 1 J Virol 1 JAMA 1 Neurology 3 Pediatr Infect Dis J 1 Pediatrics 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. KULCHYNSKA R, Sazonova Y, Azarskova M, Salyuk T, et al
   Sex disparities and partners' positive HIV status in HIV recent infection among people who inject drugs in Ukraine.
   AIDS. 2026 Jan 6. doi: 10.1097/QAD.0000000000004440.
   PubMed         Abstract available
   
   
2. FILIP I
   HIV-specific screening strategies may enhance detection of liver fibrosis in high-risk individuals.
   AIDS. 2026 Jan 7. doi: 10.1097/QAD.0000000000004441.
   PubMed        
   
   
3. DUARTE MJ, Tien PC, Kardashian A, Ma Y, et al
   Erratum: Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV.
   AIDS. 2026;40:132.
   PubMed        
   
   
4. BROWN MJ, Murtala NM, Amoatika D, Kaur A, et al
   Erratum: Clinical and sociodemographic characteristics of Alzheimer's disease and related dementias among people with HIV.
   AIDS. 2026;40:131.
   PubMed        
   
   
5. KOVALENKO G, Liulchuk MG, Filippovych M, Smyrnov P, et al
   VANTAGE: van-based real-time HIV sequencing for transmission mapping and drug resistance profiling in war-affected Ukraine.
   AIDS. 2026;40:123-126.
   PubMed         Abstract available
   
   
6. FREITAS C, Cooper CL, Kroch AE, Buchan SA, et al
   SARS-CoV-2 breakthrough infection among people with and without HIV in Ontario, Canada.
   AIDS. 2026;40:119-122.
   PubMed         Abstract available
   
   
7. CHAN PA, Mena L, Maynard MA
   Long-acting injectable lenacapavir for HIV prevention: clinical considerations during implementation.
   AIDS. 2026;40:116-118.
   PubMed        
   
   
8. DOMINGO P, Stapleton JT
   The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization.
   AIDS. 2026;40:111-113.
   PubMed        
   
   

   
   Am J Epidemiol

9. ASHBY E, Janes H, Follmann D, Gilbert PB, et al
   Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up.
   Am J Epidemiol. 2026;195:168-177.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

10. OBENG BM, Hutchinson J, Shaik A, Chetchotisakd P, et al
    Regional variations of rates and determinants of drug resistance mutations in people failing first-line therapy for HIV-1: a substudy from the D2EFT phase 3b/4 clinical trial.
    Clin Infect Dis. 2026 Jan 3:ciaf739. doi: 10.1093.
    PubMed         Abstract available
    
    
11. SURMONT M, Verheyden M, Sahebali S, Goossens M, et al
    HPV-Related Anal Precancerous Lesions in MSM: A Comparative Study of PrEP Users and HIV-Positive Individuals.
    Clin Infect Dis. 2026 Jan 5:ciaf724. doi: 10.1093.
    PubMed         Abstract available
    
    
12. THU NTM, Brown L, Hawkins O, Bloss K, et al
    Development and Clinical Evaluation of a Novel Talaromyces marneffei Mp1p Lateral Flow Assay for Rapid Diagnosis of Talaromycosis.
    Clin Infect Dis. 2026 Jan 6:ciag004. doi: 10.1093.
    PubMed         Abstract available
    
    
13. FAGAN L, Alexander S, Fifer H
    The Invisible Tide of Neisseria gonorrhoeae Treatment Failures: A Review and Commentary.
    Clin Infect Dis. 2026;81.
    PubMed         Abstract available
    
    
14. ADAMSON PC, David HM, Pham LQ, Bui HTM, et al
    Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam.
    Clin Infect Dis. 2026;81.
    PubMed         Abstract available
    
    
15. APPA A, Steiner G, Baral S, Riley E, et al
    Integrating HIV and Stimulant Use Disorder Treatment: A Pilot Implementation Effectiveness Trial of Contingency Management in HIV Care.
    Clin Infect Dis. 2026 Jan 8:ciag006. doi: 10.1093.
    PubMed         Abstract available
    
    
16. SOLOMON SS
    When Programs Vanish: The Unseen Consequences.
    Clin Infect Dis. 2026 Jan 9:ciaf731. doi: 10.1093.
    PubMed        
    
    
17. 
    Correction to: Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
    Clin Infect Dis. 2026 Jan 9:ciaf711. doi: 10.1093.
    PubMed        
    
    
18. MAKINSON A, Bani-Sadr F, Palich R, Montes B, et al
    Switch to BIC/TAF/FTC or DTG + TDF/FTC in virologically suppressed PWH: outcomes in real-world setting with and without tenofovir resistance.
    Clin Infect Dis. 2026 Jan 9:ciaf726. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

19. AKBULUT I, Varol ZS, Singil S, Filiz MN, et al
    Quality of life and associated factors among people living with HIV in Turkiye: A single-centre experience.
    HIV Med. 2026 Jan 4. doi: 10.1111/hiv.70191.
    PubMed         Abstract available
    
    
20. YAN L, Xiao Q, Tuo L, Liu Y, et al
    Long-term immune reconstitution patterns and influencing factors in people living with HIV exhibiting suboptimal immune response after 24 months of antiretroviral therapy.
    HIV Med. 2026 Jan 5. doi: 10.1111/hiv.70192.
    PubMed         Abstract available
    
    
21. FONCHAM J, Azarmju F, Shen T, Salters K, et al
    Individual characteristics and time-updated factors associated with antiretroviral treatment interruptions among people living with HIV in British Columbia, Canada.
    HIV Med. 2026 Jan 6. doi: 10.1111/hiv.70188.
    PubMed         Abstract available
    
    
22. MUSSINI C, Henegar C, Assoumou L, de Wit S, et al
    Effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE-2 study.
    HIV Med. 2026 Jan 7. doi: 10.1111/hiv.70187.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

23. BAKER P, Xiao J, Ma Y, He B, et al
    The Role of Ryan White HIV/AIDS Program Services in Sustaining Viral Suppression Among People Living with HIV: Insights from South Carolina.
    J Acquir Immune Defic Syndr. 2026 Jan 9. doi: 10.1097/QAI.0000000000003831.
    PubMed         Abstract available
    
    
24. KIMMEL AD, Stirratt M, Byrd KK, Bono RS, et al
    The trials of insurance-based Data to Care-Rx: Low enrollment in the Antiretroviral Improvement among Medicaid enrolleeS (AIMS) study.
    J Acquir Immune Defic Syndr. 2026 Jan 9. doi: 10.1097/QAI.0000000000003830.
    PubMed         Abstract available
    
    

    
    J Infect Dis

25. KANKAKA EN, Tomusange S, Kityamuweesi T, Quiros G, et al
    Estimating HIV-1 Viremic Time from Reservoir Sequence Diversity with Uncertainty Quantification.
    J Infect Dis. 2026 Jan 7:jiag020. doi: 10.1093.
    PubMed         Abstract available
    
    
26. BLAAUW MJT, Navas A, Vasquez VR, Vadaq N, et al
    Functional and transcriptional senescence profiles of CD8+ T cells associate with the presence of carotid plaques in people living with HIV.
    J Infect Dis. 2026 Jan 7:jiag018. doi: 10.1093.
    PubMed         Abstract available
    
    
27. ITO Y, Hoeltermann TA, Anjum S, Robinson L, et al
    Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series.
    J Infect Dis. 2026 Jan 5:jiaf620. doi: 10.1093.
    PubMed         Abstract available
    
    
28. BROEDLOW CA, McGaugh A, Glynn TR, Cherenack EM, et al
    Douching Is Associated With Dysregulated Rectal Mucosal Immunity in Sexual Minority Men.
    J Infect Dis. 2026 Jan 6:jiaf577. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

29. WEI-LING Y, Na X, Lin L, Yu-Ting Z, et al
    Endogenous HIV-1 Tat Promotes Cell Proliferation, Migration, and Phagocytosis in Stably Infected Macrophages by Accumulating Lactate and Activating the Autophagy/MAPK Pathway.
    J Med Virol. 2026;98:e70788.
    PubMed         Abstract available
    
    

    
    J Virol

30. BISWAS U, Bernal C, Wang R, DeStefano JJ, et al
    Correction for Biswas et al., "A novel aptamer-based dNTP assay reveals that intact HIV virions are highly stable and do not contain enough dNTPs to support DNA synthesis".
    J Virol. 2026 Jan 7:e0202825. doi: 10.1128/jvi.02028.
    PubMed        
    
    

    
    JAMA

31. ROSE MR, Flexner C, Roy V
    Subscription-Based Pricing for Lenacapavir-Learning From Hepatitis C and Cabotegravir.
    JAMA. 2026 Jan 7. doi: 10.1001/jama.2025.24404.
    PubMed        
    
    

    
    Neurology

32. ONG BA, Carlson AK
    Clinical Reasoning: Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus.
    Neurology. 2026;106:e214621.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

33. IZU A, Koen A, Jose L, Cutland C, et al
    Persistence of Antibodies at Three, Four and Five Years of Age to Ten-valent Pneumococcal Polysaccharide Protein D-conjugate Vaccine in South African Children According to HIV Status.
    Pediatr Infect Dis J. 2026;45:173-180.
    PubMed         Abstract available
    
    
34. QUAN V, Meiring S, Mashau R, Perovic O, et al
    Maternal-infant Characteristics of Preterm and Term Neonates With Bloodstream Infections in Lower-tier Hospitals in South Africa: A Cross-sectional Study.
    Pediatr Infect Dis J. 2026 Jan 7. doi: 10.1097/INF.0000000000005127.
    PubMed         Abstract available
    
    
35. NDJOLO ADA ML, Fokam J, Kamgaing N, Ambe Chenwi C, et al
    Low Rates of Virological Failure and Acquired HIV-1 Drug Resistance Among Children in Cameroon: Evidence Following Transition to Dolutegravir-based Regimens in Pediatrics.
    Pediatr Infect Dis J. 2026 Jan 7. doi: 10.1097/INF.0000000000005118.
    PubMed         Abstract available
    
    

    
    Pediatrics

36. BROWN LR, Smith M, van Schalkwyk C, Johnson LF, et al
    Epidemiology of Pediatric Tuberculosis in the Western Cape: A Population-Based Study (2017-2023).
    Pediatrics. 2026 Jan 7:e2025072223. doi: 10.1542/peds.2025-072223.
    PubMed         Abstract available
    
    

    
    PLoS One

37. DEUTOU WONDEU AL, Nka AD, Ka'e AC, Ngoufack Jagni Semengue E, et al
    MicroRNAs profiling in malaria and arbovirus coinfection: A systematic review protocol.
    PLoS One. 2026;21:e0340672.
    PubMed         Abstract available
    
    
38. KLEIN Z, Meyer SC, Schoepf IC, Weber M, et al
    Association of leukocyte count with death in people with HIV: A longitudinal study over 24 years.
    PLoS One. 2026;21:e0340678.
    PubMed         Abstract available
    
    
39. ENGLER K, Lessard D, Vicente S, Tan DHS, et al
    A multi-phase project to develop a patient-reported measure of barriers to antiretroviral therapy adherence for use in HIV care: The 7-Item I-Score.
    PLoS One. 2026;21:e0324241.
    PubMed         Abstract available
    
    
40. TABANA H, Satumba T, Cooper D, Lembani M, et al
    "... I tried to commit suicide...": Understanding the intersections between mental health, HIV and teenage pregnancy.
    PLoS One. 2026;21:e0323030.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.